Schisandrin B significantly increases expression of PI3K, Akt, and p-Akt in cancerous intestinal tissues of patients with colon cancer (Xu et al., 2012; Dai et al., 2018). The gene discussed is AKT1; the disease is malignant colon neoplasm.